2014

Danish researchers discover genetic causes of febrile seizures

26 October 2014

Febrile seizures represent a recognized serious adverse event following measles, mumps, and rubella (MMR) vaccination. Researchers from Statens Serum Institut in Copenhagen have now identified two genetic loci distinctly associated with MMR-related febrile seizures. Furthermore, they identified four additional loci associated with febrile seizures in general and independently of MMR vaccination.

Large genetic study finds link between developmental genes and risk of hypospadias

10 August 2014

By combining information from the Danish Health registries and biological samples from the Danish National Biobank, researchers at Statens Serum Institut identified 18 genomic regions relevant for a malformation in newborn boys. The findings were confirmed and followed up in an international collaboration with research groups from the Netherlands, Sweden and the USA.

More ESBL bacteria at farms with high consumption of antibiotics

13 June 2014

There is a connection between previous consumption of cephalosporin antibiotics and the amount of ESBL bacteria in pigs. At the same time, there is an increased occurrence of ESBL-producing bacteria in farm workers at farms, where ESBL bacteria have been found in pigs. These findings appear from a new study undertaken by Statens Serum Institut and the National Food Institute, Technical University of Denmark.

Patients with hereditary muscle disease have an increased risk of cardiac involvement

22 April 2014

Researchers from Statens Serum Institut report in a nationwide cohort study that the hereditary muscle disease Myotonic Dystrophy can also affect the heart.

Association between antibiotics and intestinal disorder in infants

17 March 2014

Researchers at Statens Serum Institut report in a nationwide cohort study that infants treated with macrolide antibiotics right after birth are at increased risk of the disorder pyloric stenosis. The infant’s risk is also increased if mothers are treated with macrolides during the first weeks after the infant is born.

Prevention of TB infection study underway in South Africa

11 March 2014

Novel Vaccine Trial Design Aims to Answer Key Tuberculosis Questions and Enhance Vaccine Development Strategy.

R and D News

Search in R & D news: